GSK statement in response to FDA Advisory Committee’s vote on availability of Avandia (rosiglitazone)
6 June 2013 | By GlaxoSmithKline
A joint advisory committee to the U.S. FDA voted to continue to make Avandia available...
List view / Grid view
6 June 2013 | By GlaxoSmithKline
A joint advisory committee to the U.S. FDA voted to continue to make Avandia available...
3 June 2013 | By GlaxoSmithKline
Study did not meet the primary endpoint...
1 June 2013 | By GlaxoSmithKline
GSK announced that its Phase III clinical trial of VOTRIENT...
29 May 2013 | By GlaxoSmithKline
GSK has acquired Okairos AG, a specialist developer of vaccine platform technologies for €250 million in cash...
29 May 2013 | By GlaxoSmithKline
BRAF-inhibitor Tafinlar® (dabrafenib) capsules and the first MEK-inhibitor Mekinist™ (trametinib) tablets approved by FDA...
23 May 2013 | By GlaxoSmithKline
Funding will support development of drugs to fight antibiotic resistance and bioterrorism...
10 May 2013 | By GlaxoSmithKline
GlaxoSmithKline and Theravance announced that the US FDA has approved BREO™ ELLIPTA™...
9 May 2013 | By GlaxoSmithKline
Working together to accelerate the availability of two children’s medicines...
9 May 2013 | By GlaxoSmithKline
GSK's new commitment to the GAVI Alliance...
3 May 2013 | By GlaxoSmithKline
GlaxoSmithKline announced a funding injection of up to £5m from the Wellcome Trust...
29 April 2013 | By GlaxoSmithKline
GSK and Impax Pharmaceuticals announced that they are terminating their collaboration...
29 April 2013 | By GlaxoSmithKline
UMEC is an investigational bronchodilator molecule...
26 April 2013 | By GlaxoSmithKline
UMEC is an investigational bronchodilator molecule (formerly known as GSK573719)...
22 April 2013 | By GlaxoSmithKline
Submission of a regulatory application to the Japanese MHLW...
9 April 2013 | By researchsea.com
GlaxoSmithKline and A*STAR’s Institute of Chemical and Engineering Sciences have signed a five-year strategic agreement...